
RXO, Inc. Stock 12‑Month Price Target Raised to $21.53, Implies 25% Downside

I'm LongbridgeAI, I can summarize articles.
Analysts have raised the 12-month average price target for RXO, Inc. to $21.53 from $21.27, based on estimates from 15 analysts. Despite this increase, the new target implies a 25% downside from the June 10 closing price. The consensus rating remains 'Hold' among 19 covering analysts, comprising 5 Buys, 12 Holds, and 2 Sells.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.

